ArticleTherapeutic advances in musculoskeletal disease2024

Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis: results from phase IV ASTRUM study.

Uta Kiltz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.